OTCPK:ARLZQ - Post by User
Comment by
Floridas2000on Mar 15, 2017 11:38am
132 Views
Post# 25982340
RE:RE:RE:RE:RE:RE:ARLZ will be discounted to cash
RE:RE:RE:RE:RE:RE:ARLZ will be discounted to cashI try not to sell when everyone is selling or buy when everyone is buying. When a market goes into a frenzy they always overdo it on the up (SJL) and downside (ARLZ). Investors stayed invested in ARLZ because of the sales team and acceptance of the drug along with becoming profitable this year. It won't happen this year. They got punished. But punishing it to cash too much since good news was ignored. The push to sell ARLZ in Europe. Performance of other drugs. The increase revenue yoy and qoq (yes I know last year's numbers were only for Pozen). I am still curious how Tribute's stable of drugs are doing. They don't divide out the numbers but they should be growing.
I am sitting because it's free money for me and I sold half when it doubled with Tribute. I am hoping this is a wake up call for Adams since he's heavily invested in ARLZ and is losing a lot of money. Not pleased at all but I will be patient until I'm not. Good luck to all.